Impact of reduced endogenous anti-coagulation protein activity on vascular events of peripheral arterial disease

International Angiology

Volumn 28, Issue 2, 2009, Pages 138-143

  Komai, H ^a,b   Juri, M ^a  

^a Saiseikai Wakayama Hospital   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Blood coagulation disorders; Peripheral arterial diseases; Prognosis; Surgical procedures, operative

Indexed keywords

ANTICOAGULANT PROTEIN; ANTITHROMBIN; PLASMINOGEN; PROTEIN C; PROTEIN S; BIOLOGICAL MARKER; BLOOD CLOTTING INHIBITOR;

ADULT; AGED; ANTICOAGULATION; ARTERY BYPASS; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; LEG AMPUTATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL ARTERY BYPASS GRAFTING; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL; REVASCULARIZATION; SURGICAL TECHNIQUE; THROMBOEMBOLISM; VASCULAR DISEASE; VENOUS BLOOD; AMPUTATION; ANTITHROMBIN III DEFICIENCY; BLOOD; BLOOD CLOTTING; BLOOD COAGULATION DISORDERS; COMPLICATION; DEFICIENCY; DISEASE FREE SURVIVAL; DOWN REGULATION; ISCHEMIA; JAPAN; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REOPERATION; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VASCULAR SURGERY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANTITHROMBIN III DEFICIENCY; ANTITHROMBINS; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTOR INHIBITORS; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; HUMANS; INCIDENCE; INTERMITTENT CLAUDICATION; ISCHEMIA; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PLASMINOGEN; PREVALENCE; PROTEIN C; PROTEIN C DEFICIENCY; PROTEIN S; PROTEIN S DEFICIENCY; REOPERATION; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 67650506014     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003;19:41(Suppl S):15S-22S. (Pubitemid 36223342)
2. Ray SA, Rowley MR, Bevan DH, Taylor RS, Dormandy JA. Hypercoagulable abnormalities and postoperative failure of arterial reconstruction. Eur J Vasc Endovasc Surg 1997;13:363-370 (Pubitemid 27183012)
3. Eldrup-Jorgensen J, Flanigan DP, Brace L, Sawchuk AP, Mulder SG, Anderson CP et al. Hypercoagulable states and lower limb ischemia in young adults. J Vasc Surg 1989;9:334-341 (Pubitemid 19070016)
4. Evans SM, Brittenden J, Adam DJ, Ludlam C, Bradbury AW Vascular surgical society of great britain and ireland: prevalence and significance of thrombophilia in patients with intermittent claudication. Br J Surg 1999;86:702-703
5. Makin A, Silverman SH, Lip GYH. Peripheral vascular disease and Virchow's triad for thrombogenesis. QJM 2002;95:199-210. (Pubitemid 34413726)
6. Thomas DP, Roberts HR. Hypercoagulability in venous and arterial thrombosis. Ann Intern Med 1997;126:638-644
7. Sakata T, Kario K, Katayama Y, Matsuyama T, Kato H, Miyata T. Studies on congenital protein C deficiency in Japanese: prevalence, genetic analysis, and relevance to the onset of arterial occlusive diseases. Semin Thromb Hemost 2000;26:11-16 (Pubitemid 30238011)
8. Suehisa E, Nomura T, Kawasaki T, Kanakura Y. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagul Fibrinolysis 2001;12:95-99 (Pubitemid 32234816)
9. Nomura T, Suehisa E, Kawasaki T, Okada A. Frequency of protein S deficiency in general Japanese population. Thromb Res 2000;100:367-371 (Pubitemid 32056967)
10. Kikuchi S, Yamanouchi Y, Li L, Kobayashi K, Ijima H, Miyazaki R et al. Plasminogen with type-I mutation is polymorphic in the Japanese population. Hum Genet 1992;90:7-11.
11. Okamoto A, Sakata T, Mannami T, Baba S, Katayama Y, Matsuo H et al. Population-based distribution of plasminogen activity and estimated prevalence and relevance to thrombotic diseases of plasminogen deficiency in the Japanese: the Suita Study. J Thromb Haemost 2003;1:2397-403.
12. Sakata T, Kario K, Katayama Y, Matsuyama T, Kato H, Miyata T. Analysis of 45 eisodes of arterial occlusive disease in Japanese patients with congenital protein C deficiency. Thromb Res 1999;94:69-78. (Pubitemid 29197373)
13. Sampram ES, Lindblad B, Dahlback B. Activated protein C resistance in with peripheral vascular disease. J Vasc Surg 1998;28:624-629 (Pubitemid 28481215)
14. Ouriel K, Green RM, DeWeese JA, Cimino C. Activated protein C resistance: prevalence and implications in peripheral vascular disease. J Vasc Surg 1996;23:46-51. (Pubitemid 26037962)
15. Curi MA, Skelly CL, Baldwin ZK, Woo DH, Baron JM, Desai TR et al. Long-term outcome of infrainguinal bypass grafting in patients with serologically proven hypercoagulability. J Vasc Surg 2003;37:301-306 (Pubitemid 36236906)
16. Nagayama T, Shinohara Y, Nagayama M, Tsuda M, Yamamura M. Congenitally abnormal plasminogen in juvenile ischemic cerebrovascular disease. Stroke 1993;24:2104-7.
17. Vig S, Chitolie A, Sleight S, Bevan D, Dormandy J, Thompson MM et al. Prevalence and risk of thrombophilia defects in vascular patients. Eur J Vasc Endovasc Surg 2004;28:124-131